Manoj Mohan, DO
Allergy & Immunology · Okemos, MINPI 1821295213
Payments from drug & device makers
Across 516 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Sanofi$958
- Genentech USA, Inc.$532
- Optinose US, Inc.$514
- Regeneron Healthcare Solutions, Inc.$453
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 129 | $2,520 |
| GSK | 87 | $1,510 |
| Sanofi | 42 | $958 |
| Genentech USA, Inc. | 27 | $532 |
| Optinose US, Inc. | 26 | $514 |
| Regeneron Healthcare Solutions, Inc. | 17 | $453 |
| Pfizer | 21 | $335 |
| Novartis | 15 | $313 |
| CSL Behring | 13 | $286 |
| Alk-abello, Inc | 14 | $264 |
| Teva Pharmaceuticals USA, Inc. | 16 | $232 |
| Pharming Healthcare, Inc. | 12 | $222 |
| Grifols USA, LLC | 12 | $218 |
| Kaleo, Inc. | 12 | $194 |
| Boehringer Ingelheim | 10 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $161 |
| AbbVie | 3 | $158 |
| Amgen | 8 | $134 |
| Organon | 7 | $112 |
| Shire North American Group Inc | 5 | $90 |
| Biocryst US Sales Co., LLC | 3 | $84 |
| Covis Pharma GmbH | 5 | $72 |
| Phadia US Inc. | 4 | $69 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Hikma Pharmaceuticals USA | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Octapharma USA, Inc. | 2 | $30 |
| Biocryst Pharmaceuticals, Inc. | 1 | $21 |
| Circassia Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $12 |
How this compares
$10,000 in reported general payments places this provider in the 70th percentile of 119 allergy & immunology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Okemos
- Jeffrey LefleinYpsilanti$7.9M
- Cem AkinNorthville$3M
- Alan BaptistAnn Arbor$2.5M
- Suresh AnneFlint$1.1M
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
- Theodore KelbelGrand Rapids$695K
- Rajan RavikumarBrighton$661K
- Georgiana SandersAnn Arbor$607K
- Nicholas HartogGrand Rapids$581K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.